Literature DB >> 306890

Role of self carriers in the immune response and tolerance. III. B cell tolerance induced by hapten-modified-self involves both active T cell-mediated suppression and direct blockade.

D W Scott.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 306890     DOI： 10.1016/0008-8749(78)90201-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  8 in total

1.  Accessory cell presentation of hapten-modified self.

Authors:  J P Cogswell; D W Scott
Journal:  Surv Immunol Res       Date:  1985

2.  Immune suppression in vivo with antigen-modified syngeneic cells. I. T-cell-mediated suppression to the terpolymer poly-(Glu, Lys, Phe)n.

Authors:  N K Cheung; D H Scherr; K M Heghinian; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

3.  Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

Authors:  J Z Weinberger; R N Germain; S T Ju; M I Greene; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

4.  Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen.

Authors:  I Burrai; B Henderson; S C Knight; N A Staines
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

5.  Nucleic acid-specific suppressor T cells.

Authors:  Y Borel; M C Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens.

Authors:  J J Jandinski; J Li; P J Wettstein; J A Frelinger; D W Scott
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

7.  Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor.

Authors:  R N Germain; C Waltenbaugh; B Benacerraf
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

8.  T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes.

Authors:  A K Abbas; S E Ratnofsky; S J Burakoff
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.